MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020

Rhea-AI Summary

MiMedx Group, Inc. (OTC PINK: MDXG) announced that its common stock will begin trading on The Nasdaq Stock Market from November 4, 2020. This move marks a significant milestone for the company, which specializes in advanced wound care and therapeutic biologics. MiMedx is recognized for its development and distribution of human placental tissue allografts using its proprietary PURION® process. The company has successfully supplied over two million allografts to the healthcare sector.

Positive

• Commencement of trading on Nasdaq under the ticker symbol 'MDXG' enhances visibility and credibility.
• Established reputation as an industry leader in advanced wound care and therapeutic biologics.

Negative

• None.

MARIETTA, Ga., Nov. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today confirmed that the Company’s common stock will commence trading on The Nasdaq Stock Market at the opening of trading on Wednesday, November 4, 2020, under the ticker symbol “MDXG”.

About MiMedx

MiMedx^® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION^® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact

Hilary Dixon
Investor Relations & Corporate Communications
770.651.9066
investorrelations@mimedx.com

FAQ

When will MiMedx start trading on Nasdaq under the symbol MDXG?

MiMedx will start trading on Nasdaq on November 4, 2020.

What is the significance of MiMedx trading on Nasdaq?

Trading on Nasdaq enhances MiMedx's visibility and credibility in the stock market.

What products does MiMedx specialize in?

MiMedx specializes in advanced wound care and therapeutic biologics, particularly human placental tissue allografts.

What process does MiMedx use to produce its allografts?

MiMedx uses its proprietary PURION® process methodology to produce human placental tissue allografts.